AFP and hepatocellular carcinoma: AFP ≥ 200 ng/μl can predict the DFS of AFP-positive HCC patients after hepatectomy (AFP ≥ 200 ng/μl vs. AFP < 200 ng/μl, 18.67 vs. 26.47 months, p = 0.0166; HR, 1.24, 95% CI, 1.04-1.48), but not OS (p = 0.5094; HR, 1.13, 95% CI, 0.79-1.62).